 |
인쇄하기
취소
|
Daihan Pharm share jumps on stock market
Daehan Pharm's stock rose sharply after its successful completion of preclinical trials over a degenerative arthritis medication on February 12.
Daehan gained 395 won to 3,030 won on February 14.
Daihan said it has preclinically studied a new degenerative osteoarthritis drug, which found to be effective in animal models, as a result of its joint research with local practitioners.
The ...
Daehan gained 395 won to 3,030 won on February 14.
Daihan said it has preclinically studied a new degenerative osteoarthritis drug, which found to be effective in animal models, as a result of its joint research with local practitioners.
The ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.